TABLE 1.

Patient baseline demographic and clinical characteristics

Variables	Values
Number of patients (N)	34
Age (years, median [range])	51.7 (24.3–80.0)
Weight (kg, median [range])	87.1 (50.5–135.6)
Sex (N, %)
Male	33 (97.1)
Female	1 (2.9)
Blood type (N,%)
Type O	13 (38.2)
Other blood type	21 (61.8)
Haemoglobin (g/dl, median [range])	13.1 (5.8–16.7)
Haematocrit (%, median [range])	38.6 (20.3–48.9)
Surgery types (N, %)
Major surgeries	51 (91.1)
Minor surgeries	5 (8.9)
Haemophilia severity
Mild (> .05 IU/ml)	11
Moderate (.01–.05 IU/ml)	5
Severe (< .01 IU/ml)	18
FVIII Dose (IU, median [range])	3560 (124.2–7944)
Product type
Monoclonal	135
Recombinant (Xyntha/Refacto)	270
Recombinant (Obizur)	13
Infusion duration
≤5 min	166
>5min to ≤1h	22
>1 h	230